The effect of A1 adenosine receptor in diabetic megalin loss with caspase-1/IL18 signaling
Dongli Tian,1 Xiaoxiao Shi,1 Yumo Zhao,1 Xiaoyan Peng,1 Linfeng Zou,1 Lubin Xu,1 Ying Ma,1 Yubin Wen,1 Robert Faulhaber-Walter,2 Limeng Chen11Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100730, P...
Guardado en:
Autores principales: | Tian D, Shi X, Zhao Y, Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R, Chen L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd35c8c0d26947ff991b91a4784ad0c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effect of A1 Adenosine Receptor in Diabetic Megalin Loss with Caspase-1/IL18 Signaling [Corrigendum]
por: Tian D, et al.
Publicado: (2020) -
New Insights into the Roles of Megalin/LRP2 and the Regulation of its Functional Expression
por: Marzolo,María-Paz, et al.
Publicado: (2011) -
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
por: Rafael Franco, et al.
Publicado: (2021) -
Cerebral A1 adenosine receptor availability in female and male participants and its relationship to sleep
por: Anna L. Pierling, et al.
Publicado: (2021) -
Caspase-1 Inhibitor Reduces Pyroptosis Induced by Brain Death in Kidney
por: Weifeng Liu, et al.
Publicado: (2021)